
Christopher C. Caillouet
Examiner (ID: 8951, Phone: (571)270-3968 , Office: P/1745 )
| Most Active Art Unit | 1745 |
| Art Unit(s) | 1791, 1745 |
| Total Applications | 862 |
| Issued Applications | 546 |
| Pending Applications | 67 |
| Abandoned Applications | 259 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4894074
[patent_doc_number] => 20080103173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-01
[patent_title] => 'Compounds Having Activity At Nk3 Receptor And Uses Thereof In Medicine'
[patent_app_type] => utility
[patent_app_number] => 11/718910
[patent_app_country] => US
[patent_app_date] => 2005-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8906
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20080103173.pdf
[firstpage_image] =>[orig_patent_app_number] => 11718910
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/718910 | Compounds Having Activity At Nk3 Receptor And Uses Thereof In Medicine | Nov 9, 2005 | Abandoned |
Array
(
[id] => 7688800
[patent_doc_number] => 20070105898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Process for the production of cilostazol'
[patent_app_type] => utility
[patent_app_number] => 11/269541
[patent_app_country] => US
[patent_app_date] => 2005-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2780
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20070105898.pdf
[firstpage_image] =>[orig_patent_app_number] => 11269541
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/269541 | Process for the production of cilostazol | Nov 8, 2005 | Abandoned |
Array
(
[id] => 5743619
[patent_doc_number] => 20060089344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Derivatives of piperidinyl-and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics'
[patent_app_type] => utility
[patent_app_number] => 11/262211
[patent_app_country] => US
[patent_app_date] => 2005-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16470
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20060089344.pdf
[firstpage_image] =>[orig_patent_app_number] => 11262211
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/262211 | Derivatives of piperidinyl-and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics | Oct 27, 2005 | Issued |
Array
(
[id] => 5808399
[patent_doc_number] => 20060094754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Quinolines as allosteric enhancers of the GABAB receptors'
[patent_app_type] => utility
[patent_app_number] => 11/259860
[patent_app_country] => US
[patent_app_date] => 2005-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12401
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094754.pdf
[firstpage_image] =>[orig_patent_app_number] => 11259860
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/259860 | Quinolines as allosteric enhancers of the GABAB receptors | Oct 26, 2005 | Issued |
Array
(
[id] => 5808400
[patent_doc_number] => 20060094755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Novel quinoline-based metal chelators as antiviral agents'
[patent_app_type] => utility
[patent_app_number] => 11/260780
[patent_app_country] => US
[patent_app_date] => 2005-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7411
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094755.pdf
[firstpage_image] =>[orig_patent_app_number] => 11260780
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/260780 | Novel quinoline-based metal chelators as antiviral agents | Oct 26, 2005 | Abandoned |
Array
(
[id] => 5614441
[patent_doc_number] => 20060116369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Certain compounds, compositions, and methods'
[patent_app_type] => utility
[patent_app_number] => 11/257751
[patent_app_country] => US
[patent_app_date] => 2005-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15010
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20060116369.pdf
[firstpage_image] =>[orig_patent_app_number] => 11257751
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/257751 | Certain compounds, compositions, and methods | Oct 23, 2005 | Abandoned |
Array
(
[id] => 5743656
[patent_doc_number] => 20060089381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Method of producing Ethyl (3R, 5S, 6E)-7-[2 cyclopropyl-4-(fluorophenyl) quinoline-3-yl]-3, 5-dihydroxy-6-heptenoate'
[patent_app_type] => utility
[patent_app_number] => 11/254864
[patent_app_country] => US
[patent_app_date] => 2005-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6501
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20060089381.pdf
[firstpage_image] =>[orig_patent_app_number] => 11254864
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/254864 | Method of producing ethyl (3R, 5S, 6E)-7-[2 cyclopropyl-4-(fluorophenyl) quinoline-3-yl]-3, 5-dihydroxy-6-heptenoate | Oct 20, 2005 | Issued |
Array
(
[id] => 303752
[patent_doc_number] => 07534891
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-19
[patent_title] => 'Quinoline derivatives as H3R inverse agonists'
[patent_app_type] => utility
[patent_app_number] => 11/251509
[patent_app_country] => US
[patent_app_date] => 2005-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14349
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/534/07534891.pdf
[firstpage_image] =>[orig_patent_app_number] => 11251509
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/251509 | Quinoline derivatives as H3R inverse agonists | Oct 13, 2005 | Issued |
Array
(
[id] => 5361691
[patent_doc_number] => 20090036485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'Quinoline derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/665124
[patent_app_country] => US
[patent_app_date] => 2005-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36149
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20090036485.pdf
[firstpage_image] =>[orig_patent_app_number] => 11665124
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/665124 | Quinoline derivatives | Oct 6, 2005 | Abandoned |
Array
(
[id] => 5000385
[patent_doc_number] => 20070043019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'Salt and crystalline forms thereof of a drug'
[patent_app_type] => utility
[patent_app_number] => 11/245561
[patent_app_country] => US
[patent_app_date] => 2005-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4170
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20070043019.pdf
[firstpage_image] =>[orig_patent_app_number] => 11245561
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/245561 | Salt and crystalline forms thereof of a drug | Oct 6, 2005 | Issued |
Array
(
[id] => 6546353
[patent_doc_number] => 20100016353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS'
[patent_app_type] => utility
[patent_app_number] => 11/718115
[patent_app_country] => US
[patent_app_date] => 2005-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13335
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20100016353.pdf
[firstpage_image] =>[orig_patent_app_number] => 11718115
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/718115 | BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS | Oct 2, 2005 | Abandoned |
Array
(
[id] => 103241
[patent_doc_number] => 07723525
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-25
[patent_title] => 'Chemokine-binding heterocyclic compound salts, and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/235469
[patent_app_country] => US
[patent_app_date] => 2005-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7769
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/723/07723525.pdf
[firstpage_image] =>[orig_patent_app_number] => 11235469
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/235469 | Chemokine-binding heterocyclic compound salts, and methods of use thereof | Sep 25, 2005 | Issued |
Array
(
[id] => 5178113
[patent_doc_number] => 20070179173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-02
[patent_title] => 'Carbostyril compound'
[patent_app_type] => utility
[patent_app_number] => 10/582014
[patent_app_country] => US
[patent_app_date] => 2005-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 111662
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20070179173.pdf
[firstpage_image] =>[orig_patent_app_number] => 10582014
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/582014 | Carbostyril compound | Sep 25, 2005 | Issued |
Array
(
[id] => 4808162
[patent_doc_number] => 20080171740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-17
[patent_title] => 'Chemical Compounds'
[patent_app_type] => utility
[patent_app_number] => 11/575869
[patent_app_country] => US
[patent_app_date] => 2005-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28351
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20080171740.pdf
[firstpage_image] =>[orig_patent_app_number] => 11575869
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/575869 | Chemical Compounds | Sep 22, 2005 | Abandoned |
Array
(
[id] => 5829175
[patent_doc_number] => 20060063791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => '(Spirocyclylamido)aminothiophene compounds'
[patent_app_type] => utility
[patent_app_number] => 11/227345
[patent_app_country] => US
[patent_app_date] => 2005-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14657
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20060063791.pdf
[firstpage_image] =>[orig_patent_app_number] => 11227345
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/227345 | (Spirocyclylamido)aminothiophene compounds | Sep 14, 2005 | Abandoned |
Array
(
[id] => 5673043
[patent_doc_number] => 20060178398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Therapeutic compounds for treating dyslipidemic conditions'
[patent_app_type] => utility
[patent_app_number] => 11/226782
[patent_app_country] => US
[patent_app_date] => 2005-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25773
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20060178398.pdf
[firstpage_image] =>[orig_patent_app_number] => 11226782
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/226782 | Therapeutic compounds for treating dyslipidemic conditions | Sep 13, 2005 | Abandoned |
Array
(
[id] => 5023601
[patent_doc_number] => 20070149567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'Quinoline compounds'
[patent_app_type] => utility
[patent_app_number] => 10/576853
[patent_app_country] => US
[patent_app_date] => 2005-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27347
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20070149567.pdf
[firstpage_image] =>[orig_patent_app_number] => 10576853
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/576853 | Quinoline compounds | Sep 11, 2005 | Abandoned |
Array
(
[id] => 5794106
[patent_doc_number] => 20060014787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/223501
[patent_app_country] => US
[patent_app_date] => 2005-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24768
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014787.pdf
[firstpage_image] =>[orig_patent_app_number] => 11223501
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/223501 | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof | Sep 8, 2005 | Abandoned |
Array
(
[id] => 5057690
[patent_doc_number] => 20070060612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Antitumor agents'
[patent_app_type] => utility
[patent_app_number] => 11/223806
[patent_app_country] => US
[patent_app_date] => 2005-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7677
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20070060612.pdf
[firstpage_image] =>[orig_patent_app_number] => 11223806
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/223806 | Antitumor agents | Sep 8, 2005 | Issued |
Array
(
[id] => 5183584
[patent_doc_number] => 20070054938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Antitumor agents'
[patent_app_type] => utility
[patent_app_number] => 11/220894
[patent_app_country] => US
[patent_app_date] => 2005-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7740
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20070054938.pdf
[firstpage_image] =>[orig_patent_app_number] => 11220894
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/220894 | Antitumor agents | Sep 6, 2005 | Abandoned |